Hunan Jiudian Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Hunan Jiudian Pharmaceutical has a total shareholder equity of CN¥2.1B and total debt of CN¥393.1M, which brings its debt-to-equity ratio to 18.7%. Its total assets and total liabilities are CN¥3.0B and CN¥851.5M respectively. Hunan Jiudian Pharmaceutical's EBIT is CN¥442.7M making its interest coverage ratio 62.4. It has cash and short-term investments of CN¥655.4M.
Key information
18.7%
Debt to equity ratio
CN¥393.06m
Debt
Interest coverage ratio | 62.4x |
Cash | CN¥655.36m |
Equity | CN¥2.11b |
Total liabilities | CN¥851.46m |
Total assets | CN¥2.96b |
Recent financial health updates
Recent updates
Here's Why Hunan Jiudian Pharmaceutical (SZSE:300705) Can Manage Its Debt Responsibly
Jun 23Hunan Jiudian Pharmaceutical (SZSE:300705) Is Increasing Its Dividend To CN¥0.321
May 21Here's Why We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Might Deserve Your Attention Today
Apr 12Earnings Not Telling The Story For Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) After Shares Rise 27%
Mar 04Financial Position Analysis
Short Term Liabilities: 300705's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥357.3M).
Long Term Liabilities: 300705's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥494.1M).
Debt to Equity History and Analysis
Debt Level: 300705 has more cash than its total debt.
Reducing Debt: 300705's debt to equity ratio has increased from 8.1% to 18.7% over the past 5 years.
Debt Coverage: 300705's debt is well covered by operating cash flow (145.3%).
Interest Coverage: 300705's interest payments on its debt are well covered by EBIT (62.4x coverage).